- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07943338
Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital (SATISCHOL)
A Prospective Observational Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital
SATISCHOL is a prospective, monocentric observational study designed to assess pain management and quality of care in patients undergoing elective cholecystectomy at Limoges University Hospital, France.
The primary objective is to assess the proportion of patients reporting a visual analogue scale (VAS) pain score below 4 two hours after surgery, in association with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery.
Secondary objectives include assessing early postoperative pain, describing postoperative complications and intraoperative pain management techniques, and evaluating changes in patients' quality of life using the Gastrointestinal Quality of Life Index (GIQLI) and EQ-5D-5L questionnaires. Patient-reported experience will also be assessed using a study-specific questionnaire (PREMS).
A total of 70 participants are expected to be enrolled. Patients will be followed for approximately 3 to 6 weeks after surgery.
Visão geral do estudo
Status
Descrição detalhada
Cholecystectomy is one of the most frequently performed surgical procedures worldwide, both in elective and emergency settings. At Limoges University Hospital, 146 elective laparoscopic cholecystectomies were performed in 2024.
Cholecystectomy is indicated for the treatment of various biliary tract conditions, including biliary colic, acute or chronic cholecystitis, gallbladder polyps, gallstone pancreatitis, cholangitis and common bile duct stones.
Laparoscopic cholecystectomy, with achievement of the critical view of safety, is the standard surgical approach.
Patient-reported outcome measures (PROMs) and postoperative satisfaction have become increasingly important in the assessment of surgical outcomes and are considered key components of patient-centred care.
This study aims to assess pain management and quality of care during elective cholecystectomy at Limoges University Hospital.
Postoperative pain will be assessed using the visual analogue scale (VAS) two hours after surgery. Postoperative complications will be recorded and classified according to the Clavien-Dindo classification up to four weeks after surgery.
Intraoperative pain management techniques, including trocar-site infiltration, diaphragmatic dome infiltration with local anaesthetic and transversus abdominis plane (TAP) block, will also be documented.
Quality of life will be assessed before surgery (T0) and at postoperative follow-up (T2) using the GIQLI and EQ-5D-5L questionnaires. Patient experience will be evaluated at T2 using a study-specific PREMS questionnaire.
Data will be collected prospectively from clinical records and patient-completed questionnaires administered during the preoperative consultation and at the postoperative follow-up consultation, approximately 3 to 6 weeks after surgery.
The study is expected to contribute to the continuous improvement of pain management and quality of care for patients undergoing cholecystectomy at Limoges University Hospital.
Tipo de estudo
Inscrição (Estimado)
Contactos e Locais
Contato de estudo
- Nome: Niki CHRISTOU, Professor
- Número de telefone: 05 55 05 55 55
- E-mail: niki.christou@chu-limoges.fr
Estude backup de contato
- Nome: Oumar SECK
- E-mail: cheikhououmar.seck@chu-limoges.fr
Locais de estudo
-
-
-
Limoges, França, 87042
- Recrutamento
- Chu Limoges
-
Contato:
- Niki CHRISTOU, Professor
- Número de telefone: 05 55 05 55 55 0555058630
- E-mail: niki.christou@chu-limoges.fr
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Patients undergoing elective cholecystectomy, laparoscopic surgery or minimally invasive surgery.
Descrição
Inclusion Criteria:
- Age 18 years or older.
- Patients undergoing elective cholecystectomy.
- Patients undergoing laparoscopic surgery or minimally invasive surgery, including conversion to open laparotomy when necessary.
- Patients able to complete questionnaires independently or with the assistance of a caregiver.
- Patients covered by a health insurance scheme.
- Patients who have not objected to participation in the study.
Exclusion Criteria:
- Patients undergoing emergency surgery.
- Patients undergoing cholecystectomy when gallbladder removal is not the primary purpose of the surgical procedure.
- Patients with a history of chronic gastrointestinal disease.
- Patients with known gallbladder cancer.
- Patients scheduled for open laparotomy.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Modelos de observação: COHORT
- Perspectivas de Tempo: PROSPECTIVE
Coortes e Intervenções
Grupo / Coorte |
|---|
|
Patients undergoing elective cholecystectomy
Adult patients undergoing elective cholecystectomy at Limoges University Hospital |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Proportion of patients with a visual analogue scale (VAS) pain
Prazo: From two hours after surgery to four weeks postoperatively.
|
Proportion of patients with a visual analogue scale (VAS) pain score below 4 two hours after cholecystectomy, associated with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery. |
From two hours after surgery to four weeks postoperatively.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Proportion of patients with a VAS pain score
Prazo: Two hours after surgery.
|
Proportion of patients with a VAS pain score below 4 two hours after cholecystectomy. |
Two hours after surgery.
|
|
Proportion of patients experiencing early postoperative complications
Prazo: Up to four weeks after surgery.
|
Proportion of patients experiencing early postoperative complications, classified according to the Clavien-Dindo classification. |
Up to four weeks after surgery.
|
|
Description of intraoperative pain management techniques
Prazo: During surgery
|
Assessment of intraoperative analgesic techniques used during surgery, including: local anaesthetic infiltration at trocar insertion sites, local anaesthetic infiltration of the diaphragmatic dome, transversus abdominis plane (TAP) block . For each technique performed, the type of local anaesthetic used and the administered dose will be recorded, where applicable. |
During surgery
|
|
Change in the total Gastrointestinal Quality of Life Index (GIQLI) score
Prazo: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
Change in the total Gastrointestinal Quality of Life Index (GIQLI) score between baseline (T0) and postoperative follow-up (T2) |
Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
|
Change in the EQ-5D-5L visual analogue scale (VAS)
Prazo: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
Change in the EQ-5D-5L visual analogue scale (VAS), corresponding to the patient's self-rated health status today, between baseline (T0) and postoperative follow-up (T2). |
Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
|
Description of patient-reported experience using the study-specific PREMS questionnaire
Prazo: Postoperative assessment at 3 to 6 weeks (T2)
|
Description of patient-reported experience using the study-specific PREMS questionnaire, analysed item by item. |
Postoperative assessment at 3 to 6 weeks (T2)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Niki CHRISTOU, Professor, University Hospital, Limoges
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Dor
- Manifestações Neurológicas
- Doenças do Sistema Nervoso
- Complicações pós-operatórias
- Processos Patológicos
- Doenças do aparelho digestivo
- Manifestações Neurocomportamentais
- Doenças das vias biliares
- Doenças da Vesícula Biliar
- Distúrbios Perceptivos
- Condições Patológicas, Sinais e Sintomas
- Sinais e sintomas
- Dor, Pós-operatório
- Colecistite
- Agnosia
- Colelitíase
Outros números de identificação do estudo
- 87RI24_0064 (SATISCHOL)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Individual participant data collected during this study will not be made publicly available. Data will be handled in accordance with applicable data protection regulations and institutional policies.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .